Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
A randomised phase II study investigating durvalumab in a... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study
0
Authors
S. Loibl
24 more
S. Loibl
•
Nicole Burchardi
22 more
•
Andreas Schneeweiß
Published
May 7, 2019
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Annals of Oncology
Topics
Chemistry
Biochemistry
Medicine
Cancer Oncology
Pathology
Show all topics
DOI
10.1093/annonc/mdz158
License
publisher-specific-oa
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Annals of Oncology
Topics
Chemistry
Biochemistry
Medicine
Cancer Oncology
Pathology
Show all topics
DOI
10.1093/annonc/mdz158
License
publisher-specific-oa
